NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

PDF) Vaccines Against COVID-19

Vaccines, Free Full-Text

Intestinal helminth infection impairs oral and parenteral vaccine

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant

Mucosal vaccines — fortifying the frontiers

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

Controlled Human Infection Models To Accelerate Vaccine

The impact of human vaccines on bacterial antimicrobial resistance

Adjuvant Development NIAID: National Institute of Allergy and

Vaccines platforms and COVID-19: what you need to know

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Accelerating Next-Generation Vaccine Development for Global